Oncotarget.net features press releases on the latest oncology research, as well as interviews from the distinguished network of authors who continue to publish their research with Oncotarget.

Tag: liver cancer

Oncotarget

The SCD1 Inhibitor Aramchol, Regorafenib, and Metformin Combine to Kill Uveal Melanoma Cells

March 31, 2026

“Aramchol and metformin interacted to modestly enhance cell death in PDX UM cells, though this was less than that caused by the combination of aramchol and the multi-kinase inhibitor regorafenib.”… read more

Oncotarget

Immune Side Effects of Liver Cancer Therapy Studied in Latin American Patients

May 23, 2025

“This study provides valuable insights into the incidence and impact of irAEs in patients with HCC treated with the combination of atezolizumab and bevacizumab in real-world practice.” BUFFALO, NY -… read more

Oncotarget

AI That Measures Its Own Uncertainty Could Improve Liver Cancer Detection

April 8, 2025

“These advancements, by providing more reliable and efficient diagnostic tools, may significantly impact clinical practice by addressing the ever-growing clinical demand and work pressure, while maintaining interpretability and clinical relevance.”… read more

Oncotarget

Oncotarget | Expression of p-STAT3 and c-Myc Correlates With P2-HNF4α Expression in Nonalcoholic Fatty Liver Disease (NAFLD)

December 6, 2022

“In conclusion, our results suggest that STAT3 phosphorylation occurs in livers with NAFLD only in the subset with P2-HNF4α expression, and c-Myc expression is strongly correlated with STAT3 phosphorylation.” Listen… read more

Oncotarget

Oncotarget | Essential Amino Acids as Diagnostic Biomarkers of Hepatocellular Carcinoma Based on Metabolic Analysis

December 1, 2022

“The current and previous findings provide a rationale for further investigations into the potential utility of leucine, valine, and tryptophan as diagnostic and prognostic biomarkers for HCC.” Listen to an… read more